Logo of The Journal of Bone & Joint Surgery (Br)
Quick search:        
          Advanced Search
Guest Access | Sign In
Journal of Bone and Joint Surgery - British Volume, Vol 89-B, Issue 1, 121-126.
doi: 10.1302/0301-620X.89B1.17077  
Copyright © 2007 by British Editorial Society of Bone and Joint Surgery
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jensen, T. B.
Right arrow Articles by Søballe, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Jensen, T. B.
Right arrow Articles by Søballe, K.

Osteogenic protein-1 increases the fixation of implants grafted with morcellised bone allograft and ProOsteon bone substitute

AN EXPERIMENTAL STUDY IN DOGS

T. B. Jensen, MD, PhD, Orthopaedic Surgeon1; S. Overgaard, MD, DMSc, Orthopaedic Surgeon, Professor2; M. Lind, MD, PhD, DMSc, Orthopaedic Surgeon3; O. Rahbek, MD, PhD, Orthopaedic Surgeon1; C. Bünger, MD, DMSc, Orthopaedic Surgeon, Professor3; and K. Søballe, MD, DMSc, Orthopaedic Surgeon, Professor3

1 Orthopaedic Research Group
2 Department of Orthopaedics, Odense University Hospital, DK 5000 Odense C, Denmark.
3 Department of Orthopaedics, Åarhus University Hospital, DK 8000, Åarhus C, Denmark.

Correspondence should be sent to Dr T. B. Jensen; e-mail: tbj{at}webspeed.dk

Impacted bone allograft is often used in revision joint replacement. Hydroxyapatite granules have been suggested as a substitute or to enhance morcellised bone allograft. We hypothesised that adding osteogenic protein-1 to a composite of bone allograft and non-resorbable hydroxyapatite granules (ProOsteon) would improve the incorporation of bone and implant fixation. We also compared the response to using ProOsteon alone against bone allograft used in isolation. We implanted two non-weight-bearing hydroxyapatite-coated implants into each proximal humerus of six dogs, with each implant surrounded by a concentric 3 mm gap. These gaps were randomly allocated to four different procedures in each dog: 1) bone allograft used on its own; 2) ProOsteon used on its own; 3) allograft and ProOsteon used together; or 4) allograft and ProOsteon with the addition of osteogenic protein-1.

After three weeks osteogenic protein-1 increased bone formation and the energy absorption of implants grafted with allograft and ProOsteon. A composite of allograft, ProOsteon and osteogenic protein-1 was comparable, but not superior to, allograft used on its own.

ProOsteon alone cannot be recommended as a substitute for allograft around non-cemented implants, but should be used to extend the volume of the graft, preferably with the addition of a growth factor.




This article has been cited by other articles:


Home page
 J Bone Joint Surg BrHome page
T. W. Axelrad, B. Steen, D. W. Lowenberg, W. R. Creevy, and T. A. Einhorn
Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients
J Bone Joint Surg Br, December 1, 2008; 90-B(12): 1617 - 1622.
[Abstract] [Full Text] [PDF]


(c) British Editorial Society of Bone and Joint Surgery All Rights Reserved
Registered charity no: 209299     Print ISSN: 0301-620X
Hip, Knee, Trauma, Upper limb, Foot & Ankle, Paediatrics, Oncology, Spine, Arthroplasty, General